October 13, 2020 IntegriChain Launches GTN Analytics, Improving Visibility and Predictability of Life Science’s Critical Forecasting and Accrual Processes IntegriChain launches GTN Analytics, a new offering complementing the company’s Gross-to-Net (GTN) applications and managed services. GTN Analytics improves Life Sciences manufacturers’ visibility to comprehensive market access datasets that power the accuracy of GTN accruals and forecasting processes, delivers best practices GTN reports and metrics, and offers visualizations of GTN trends for better contract predictability and decision-making. This release advances IntegriChain’s strategy to deliver the industry’s first Market Access data access and visualization platform, powering the company’s applications, data products, and managed services.
September 10, 2020 IntegriChain Opens Registration for Access Insights Virtual Summit tegriChain has opened registration for the Access Insights Virtual Summit 2020, to be held October 20 to 22, 2020. The summit includes thought leadership sessions focused on addressing key market access challenges for Life Sciences manufacturers. Details and registration for the summit can be found at https://www.integrichain.com/access-insights/.
September 3, 2020 IntegriChain Subject Matter Experts to Present at MDRP IntegriChain subject matter experts will present at the upcoming Medicaid Drug Rebate Program (MDRP) Conference, September 14-18.
August 5, 2020 IntegriChain Subject Matter Experts to Present at CBI Accounting & Reporting Congress Several IntegriChain subject matter experts will present at the upcoming CBI Accounting and Reporting Congress. The virtual conference runs August 10-13, with a Commercial Forecasting and Modeling Summit following on August 18.
July 28, 2020 IntegriChain Supports 72% of YTD 2020 Life Sciences Launches IntegriChain's ICyte Platform, the leading launch readiness platform for Market Access data, advisory, and managed services, has supported 72% of NDA and BLA launches so far this year. Life Sciences manufacturers of all size and complexity rely on the ICyte market access and commercialization platform, offering world-class channel and patient data aggregation and stewardship, the largest offering of contracts and pricing managed services to stand up their business infrastructure, gross-to-net forecasting and accrual systems, and launch and pricing transparency advisory.
July 22, 2020 IntegriChain Summer Release Advances Patient Data Insights and Actionability of Industry-Leading ICyte Access Platform IntegriChain launches the summer release of its ICyte Platform of access data and analytics solutions. The release delivers a new Data Quality Cockpit, employing data science advancements and new integrations that detect patient data quality issues in near real time and improve patient access to critical therapies at specialty pharmacies.
June 25, 2020 IntegriChain Appoints Experienced Product Leader to Guide Data Products and Analytics Platform IntegriChain appoints Dharma Subramanian, a seasoned product leader, as Vice President, Data Products and ICyte Analytics. Subramanian delivers more than 15 years of product management and leadership including roles at Reltio, Veeva Systems, IBM, and Unisys. At IntegriChain, he will be responsible for the company’s channel and patient data and analytics products as well as the unified ICyte access data and business process platform.
June 24, 2020 CEO Council for Growth and IntegriChain Sponsor Educational Webinar Series for Emerging Cell and Gene Therapy Companies IntegriChain and the Chamber of Commerce for Greater Philadelphia’s regional CEO Council for Growth’s Cell & Gene Therapy and Connected Health Initiative will offer a complimentary educational series for emerging cell and gene therapy companies. Focused on launch and commercial readiness, the three-part webinar series begins on Thursday, June 25.
May 18, 2020 IntegriChain Featured in Gartner’s Market Guide for Revenue Management IntegriChain is prominently featured in Gartner’s new Market Guide for Revenue Management in Pharmaceuticals and Biotechnology, which is available here from the Gartner.com website. Following IntegriChain’s acquisition of the Life Sciences Division of Cumberland last month, the report highlights the combined company’s flexible and agile revenue management data, analytics, and managed services platform.
